Protalix BioTherapeutics (PLX) Short term Debt (2016 - 2024)

Protalix BioTherapeutics' Short term Debt history runs 7 years deep, the most recent figure standing at $20.4 million for Q2 2024.

• In Q2 2024, Short term Debt changed N/A year-over-year to $20.4 million; the TTM figure through Jun 2024 stood at $20.4 million (changed N/A YoY), while the FY2023 annual figure was $20.3 million, changed N/A from the prior year.
• Short term Debt was $20.4 million for Q2 2024 at Protalix BioTherapeutics, roughly flat from $20.4 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $56.4 million in Q2 2021 to a low of $3.2 million in Q3 2021.
• Historically, Short term Debt has averaged $31.3 million across 4 years, with a median of $20.4 million in 2024.